Literature DB >> 25807073

5% Minoxidil: treatment for female pattern hair loss.

Aditya K Gupta1, Kelly A Foley2.   

Abstract

Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. While 5% minoxidil foam has been approved for men since 2006, Health Canada and the FDA only approved 5% minoxidil foam for female pattern hair loss (FPHL) in 2014. Recent Phase III clinical trials demonstrated the efficacy of once daily 5% minoxidil foam for treatment of FPHL, where a significant change from baseline in the target area hair count was observed compared to placebo. Similar changes in hair count for 5% foam and twice daily 2% minoxidil solution established noninferiority of the 5% foam formulation. Five percent minoxidil foam provides an additional option for women with FPHL and will soon be available in Canada.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25807073

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  8 in total

1.  Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair loss.

Authors:  Yang Liu; Lin-Lang Jiang; Fang Liu; Qian Qu; Zhe-Xiang Fan; Zhi Guo; Yong Miao; Zhi-Qi Hu
Journal:  Lasers Med Sci       Date:  2020-10-17       Impact factor: 3.161

2.  Scalp vascularization as a marker of topical minoxidil treatment efficacy in patients with androgenetic alopecia.

Authors:  Karolina Kozicka; Adriana Łukasik; Maciej Pastuszczak; Grzegorz Dyduch; Agata Kłosowicz; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2021-02-19       Impact factor: 1.664

Review 3.  Pharmacological Management of Pattern Hair Loss.

Authors:  Sandeep Suresh Sattur; Indu Sandeep Sattur
Journal:  Indian J Plast Surg       Date:  2021-12-13

4.  Regulation of Cytokines and Dihydrotestosterone Production in Human Hair Follicle Papilla Cells by Supercritical Extraction-Residues Extract of Ulmus davidiana.

Authors:  Ye-Eun Kwon; Sun-Eun Choi; Kwang-Hyun Park
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

5.  Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth.

Authors:  Ai-Ho Liao; Ying-Jui Lu; Yi-Chun Lin; Hang-Kang Chen; Huey-Kang Sytwu; Chih-Hung Wang
Journal:  Theranostics       Date:  2016-04-11       Impact factor: 11.556

6.  Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process.

Authors:  Dominic Burg; Masakuni Yamamoto; Masato Namekata; Joseph Haklani; Koichiro Koike; Maria Halasz
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-02-27

7.  In Vitro Hair Growth Promoting Effect of a Noncrosslinked Hyaluronic Acid in Human Dermal Papilla Cells.

Authors:  Nicola Zerbinati; Sabrina Sommatis; Cristina Maccario; Maria C Capillo; Serena Di Francesco; Raffaele Rauso; Marina Protasoni; Edoardo D'Este; Daniela Dalla Gasperina; Roberto Mocchi
Journal:  Biomed Res Int       Date:  2021-10-31       Impact factor: 3.411

Review 8.  Traditional Chinese Medicine Treatment for Androgenetic Alopecia Based on Animal Experiments: A Systematic Review and Meta-Analysis.

Authors:  Yanbo Liang; Jing Yuan; Nururshopa Eskander Shazada; Jun Jiang; Jianlin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.